6 research outputs found

    Metformin reduces lipid stores and causes intestinal fluid imbalance.

    No full text
    <p>(<b>A</b>) Quantitation of triacylglycerides (TAGs) in flies treated with 0 mM, 1 mM, 10 mM and 100 mM metformin for 7 days. TAG levels decrease with increasing metformin concentration with significantly lower levels in the 10 mM and 100 mM metformin groups compared to untreated controls (<i>P</i><0.05, nβ€Š=β€Š10 (2 flies per replicate)). (<b>B</b>) Metformin treatment of female flies does not affect the number of fecal deposits produced per fly over a 24 hour period (<i>P>0.05</i>, Wilcoxen test, nβ€Š=β€Š5 (5 flies per replicate)). (<b>C</b>) Metformin treatment of female flies does not affect the size of fecal deposits as measured by the mean area of deposits (<i>P>0.05</i>, Wilcoxen test, nβ€Š=β€Š5 (5 flies per replicate)). (<b>D</b>) Female flies fed with 100 mM metformin produce more concentrated fecal deposits as measured by increased average dye intensity (<i>P</i><0.05, Wilcoxen test, nβ€Š=β€Š5 (5 flies per replicate)). (<b>E</b>) Female flies fed with 100 mM metformin produce more RODs as a percentage of their total excreta output (<i>P</i><0.05, Wilcoxen test, nβ€Š=β€Š5 (5 flies per replicate)).</p

    Metformin does not increase lifespan in <i>Drosophila.</i> A.

    No full text
    <p>Survival curves of wild-type (<i>Dahomey</i>) males and females maintained on food containing no metformin or final concentrations of 1 mM, 2.5 mM or 5 mM metformin. No significant differences in survival were observed between metformin treated flies and non-treated controls by the Log-rank test. For males, median survival times on 0 mM, 1 mM, 2.5 mM and 5 mM metformin were 57 (nβ€Š=β€Š96), 59 (nβ€Š=β€Š96), 55 (nβ€Š=β€Š97) and 57 (nβ€Š=β€Š96) days, respectively. For females, median survival times were 67 days for all conditions (0 mM nβ€Š=β€Š96, 1 mM nβ€Š=β€Š96, 2.5 mM nβ€Š=β€Š99 and 5 mM nβ€Š=β€Š91). <b>B.</b> Survival curves of wild-type (<i>Dahomey</i>) males and females maintained on food containing no metformin or final concentrations of 5 mM, 10 mM, 25 mM, 50 mM or 100 mM metformin. The survival curves for males maintained on 0 mM, 5 mM, 10 mM, 25 mM and 50 mM are not significantly different, while males maintained on 100 mM metformin were significantly shorter lived than non-treated controls (<i>P</i><0.0001 by the Log-rank test). Median survival times for males on 0 mM, 5 mM, 10 mM, 25 mM, 50 mM and 100 mM metformin were 54 (nβ€Š=β€Š97), 58 (nβ€Š=β€Š91), 51 (nβ€Š=β€Š93), 51 (nβ€Š=β€Š93), 51 (nβ€Š=β€Š98) and 37 (nβ€Š=β€Š99) days, respectively. The survival curves for females maintained on 0 mM, 5 mM and 10 mM metformin are not significantly different. Females maintained on 25 mM, 50 mM and 100 mM metformin were significantly shorter lived than non-treated controls (<i>P</i><0.001 by the Log-rank test). Median survival times for females on 0 mM, 5 mM, 10 mM, 25 mM, 50 mM and 100 mM metformin were 65 (nβ€Š=β€Š96), 65 (nβ€Š=β€Š100), 63 (nβ€Š=β€Š98), 58 (nβ€Š=β€Š101), 51 (nβ€Š=β€Š91) and 22 (nβ€Š=β€Š99) days respectively.</p

    Effects of metformin on female egg-laying and post-reproductive survival.

    No full text
    <p>(<b>A</b>) Egg-laying profiles of wild-type females treated with 0 mM, 5 mM, 10 mM, 25 mM, 50 mM and 100 mM metformin. Eggs were counted from 10 vials per treatment (10 females per vial) over a 24 hour period after 7, 14 and 21 days of metformin treatment. Data are shown as means Β±SEM. * denotes statistically significant difference (<i>P</i><0.05). No significant differences were observed in egg-laying between females on 0 mM, 5 mM and 10 mM metformin at any time point. After 7 days of treatment, females on 25 mM and 50 mM metformin laid significantly more eggs than untreated controls. After 14 days of treatment, females on 50 mM laid significantly fewer eggs than untreated controls. Females on 100 mM metformin laid significantly fewer eggs than untreated controls at all time points. (<b>B</b>) Survival curves for post-reproductive wild-type females maintained on food containing no metformin or final concentrations 25 mM and 50 mM metformin. Flies (nβ€Š=β€Š250 for each concentration) were switched onto food containing metformin at 39 days of age (red arrow). Females maintained on 25 mM or 50 mM showed reduced survival compared to flies maintained in the absence of metformin (<i>P</i><0.001 by the Log-rank test).</p

    Metformin treatment of adult <i>Drosophila</i> activates AMPK. A.

    No full text
    <p>Mass spectrometric determination of metformin concentration in whole fly extracts. Female flies were sampled after 7 days of metformin treatment at concentrations of 1, 10 and 100 mM. Before sampling, flies were incubated in the absence of metformin for 5 hours to allow for gut emptying. A dose-dependent increase in metformin accumulation in fly tissues was observed. Data are represented as the mean of three independent replicate samples Β± SEM. <b>B.</b> Western blot analysis of phospho-Thr172-AMPK expression in whole-fly protein extracts. Flies were sampled after 7 days of metformin treatment at concentrations of 0, 5, 10, 25, 50 and 100 mM. A dose-dependent increase in phospho-Thr172-AMPK levels was observed. Actin was used as a loading control.</p

    Ubiquitous adult-induced expression of dsRNA targeting <i>lacZ</i> for RNAi, or of <i>Dicer2</i>, shortens lifespan in <i>Drosophila</i> females.

    No full text
    <p>A Mated <i>ActGS>lacZRNAi</i> female flies of the indicated genotype were fed 1 SYA food containing RU486 (red lines) or not (black lines) from day two of adulthood. Log-rank test detected significant differences between the induced and uninduced conditions (pβ€Š=β€Š0.004, nβ€Š=β€Š ∼120 per condition). B Same as in A but for <i>ActGS>Dcr2</i>. Log-rank test detected significant differences between the induced and uninduced conditions (pβ€Š=β€Š0.0006, nβ€Š=β€Š ∼150 per condition).</p

    Ubiquitous adult-induced expression of dsRNA targeting <i>GFP</i> for RNAi shortens lifespan in <i>Drosophila</i> females.

    No full text
    <p>Mated female flies of the indicated genotype were fed 1 SYA food containing RU486 (red lines) or not (black lines) from day two of adulthood. <b>A</b> and <b>B</b> Log-rank test detected significant differences between the induced and uninduced conditions (p<0.0001, nβ€Š=β€Š ∼100 per condition). <b>C</b>, <b>D</b> and <b>E</b> Log-rank test did not detected significant differences between the induced and uninduced conditions (p>0.05, nβ€Š=β€Š ∼100 per condition).</p
    corecore